NCT05474586View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee

NACompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

August 8, 2022

Primary Completion Date

July 4, 2023

Study Completion Date

July 4, 2023

Conditions
Osteoarthritis, Knee
Interventions
OTHER

Collavant n2 40 mg/day

2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days

OTHER

Glucosamine hydrochloride & Chondroitin sulfate

2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days

OTHER

Microcrystalline cellulose

2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days

Trial Locations (10)

380015

Amber Clinic, Ahmedabad

400053

Prme Orthopedic Speciality, Mumbai

400064

Diamond Hospital, Mumbai

400067

Ayush Nursing Home, Mumbai

401208

Gayatri Hospital, Vasai

401209

Care n Cure Multispeciality Hospital, Pālghar

410206

Sparsh Hospital, Panvel

411057

Lifepoint Multispeciality Hospital, Pune

411062

Imperial Multispecialty Hospital, Pune

422009

Life Care Hospital, Nashik

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY